全文获取类型
| 收费全文 | 39741篇 |
| 免费 | 3247篇 |
| 国内免费 | 645篇 |
专业分类
| 耳鼻咽喉 | 618篇 |
| 儿科学 | 693篇 |
| 妇产科学 | 920篇 |
| 基础医学 | 5530篇 |
| 口腔科学 | 1306篇 |
| 临床医学 | 3673篇 |
| 内科学 | 7268篇 |
| 皮肤病学 | 763篇 |
| 神经病学 | 2844篇 |
| 特种医学 | 2004篇 |
| 外国民族医学 | 3篇 |
| 外科学 | 6066篇 |
| 综合类 | 1401篇 |
| 现状与发展 | 1篇 |
| 一般理论 | 12篇 |
| 预防医学 | 1964篇 |
| 眼科学 | 1013篇 |
| 药学 | 3539篇 |
| 7篇 | |
| 中国医学 | 623篇 |
| 肿瘤学 | 3385篇 |
出版年
| 2023年 | 318篇 |
| 2022年 | 729篇 |
| 2021年 | 1229篇 |
| 2020年 | 766篇 |
| 2019年 | 1116篇 |
| 2018年 | 1214篇 |
| 2017年 | 1000篇 |
| 2016年 | 1088篇 |
| 2015年 | 1586篇 |
| 2014年 | 1976篇 |
| 2013年 | 2172篇 |
| 2012年 | 3078篇 |
| 2011年 | 3059篇 |
| 2010年 | 2001篇 |
| 2009年 | 1735篇 |
| 2008年 | 2377篇 |
| 2007年 | 2277篇 |
| 2006年 | 2119篇 |
| 2005年 | 1999篇 |
| 2004年 | 1749篇 |
| 2003年 | 1511篇 |
| 2002年 | 1337篇 |
| 2001年 | 1026篇 |
| 2000年 | 991篇 |
| 1999年 | 807篇 |
| 1998年 | 339篇 |
| 1997年 | 331篇 |
| 1996年 | 282篇 |
| 1995年 | 221篇 |
| 1994年 | 211篇 |
| 1993年 | 197篇 |
| 1992年 | 348篇 |
| 1991年 | 305篇 |
| 1990年 | 274篇 |
| 1989年 | 251篇 |
| 1988年 | 216篇 |
| 1987年 | 163篇 |
| 1986年 | 141篇 |
| 1985年 | 103篇 |
| 1984年 | 111篇 |
| 1983年 | 73篇 |
| 1982年 | 69篇 |
| 1981年 | 59篇 |
| 1980年 | 64篇 |
| 1979年 | 73篇 |
| 1978年 | 52篇 |
| 1977年 | 62篇 |
| 1974年 | 44篇 |
| 1972年 | 48篇 |
| 1971年 | 46篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
Autoimmune comorbid diseases associated with lichen planus: a nationwide case–control study 
下载免费PDF全文
下载免费PDF全文 2.
3.
4.
5.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 下载免费PDF全文
下载免费PDF全文 6.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献7.
8.
Micro‐evolution of the hepatitis B virus genome in hepatitis B e‐antigen‐positive carriers: Comparison of genotypes B and C at various immune stages 下载免费PDF全文
下载免费PDF全文 9.
Miju Bae Sung Woon Chung Chung Won Lee Up Huh Min Su Kim Seung Hwan Song 《Asian journal of surgery / Asian Surgical Association》2019,42(1):235-239
Background
In Leriche syndrome, postoperative graft thrombosis remains one of the most significant clinical challenges.Methods
We reviewed 51 patients who underwent surgery for aortoiliac occlusive disease at our hospital from January 2007 to December 2014. The factors associated with graft patency were determined using the Cox proportional hazard model.Results
The 2-year prosthetic graft patency rate was 72.5%. Younger age (p = 0.017, Odd ratio (OR) = 1.112), postoperative uncontrolled hypertension (p = 0.044, OR = 3.797), and associated Trans Atlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease II (TASC II) D femoropopliteal lesion (p = 0.008, OR = 11.139) were significantly related factors for prosthetic graft patency after surgical repair. The existing comorbidities of the patients that indicated the need for axillo-bifemoral bypass seemed to be related to lower graft patency or other complications.Conclusions
For better graft patency after an open surgical repair of Leriche syndrome, strict postoperative hypertension control and distal run-off resolution are necessary. 相似文献10.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72